Search
Showing results for "1"
ENDIA (Environmental Determinants of Islet Autoimmunity) is a national observational study into the causes of Type 1 Diabetes in childhood.
ACE inhibitors and statins are well tolerated in teenagers with Type 1 Diabetes but more evidence is required to demonstrate whether they are effective
New research led by The Kids' PhD student Matthew Cooper has found that some children with T1D have an increased risk of developing vascular diseases.
Rare diseases (RD) are conditions affecting fewer than 1 in 2000 persons, with over 7000 largely genetic RDs affecting 3.5 %-5.9 % of the global population, or approximately 262.9–446.2 million people. The substantial healthcare burden and costs, such as the $1 trillion annual expense in the USA, highlight the urgent need for improved RD management. The International Rare Diseases Research Consortium (IRDiRC) addresses this need through global collaboration, aiming for timely and accurate diagnosis, development of 1000 new therapies, and methodologies to measure impact by 2027.
Citation: Sek K, Chen AXY, Cole T, Armitage JD, Tong J, ……… Waithman J, Parish IA, et al. Tumor site-directed A1R expression enhances CAR T cell
Citation: MacDonald B, Burmaz M, Baker S, et al. TrialR: critical enablers and the need for reusable Rare Disease Clinical Trial infrastructure in
Citation: Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and
The Rio Tinto Children’s Diabetes Centre; A JDRF Global Centre of Excellence (the Centre), announces inaugural Honours Scholarships for students dedicated to type 1 diabetes research.
Did you hear our head of nutrition research Dr Amelia Harray on ABC Radio recently? Listen to Amelia discuss tips to limit sugar on Halloween PLUS
During the school holidays, Diabetes WA supported three young adults to join the Leeuwin Ocean Adventure Youth Explorer Voyage aboard the STS Leeuwin II.